Morgan Stanley’s NCI, Inc. NCIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-54,729
| Closed | -$1.15M | – | 6749 |
|
|
2017
Q2 | $1.15M | Buy |
54,729
+9,588
| +21% | +$165K | ﹤0.01% | 4267 |
|
|
2017
Q1 | $679K | Sell |
45,141
-21,088
| -32% | -$296K | ﹤0.01% | 4653 |
|
|
2016
Q4 | $924K | Buy |
66,229
+6,638
| +11% | +$83.8K | ﹤0.01% | 4523 |
|
|
2016
Q3 | $690K | Sell |
59,591
-16,497
| -22% | -$206K | ﹤0.01% | 4305 |
|
|
2016
Q2 | $1.07M | Sell |
76,088
-12,892
| -14% | -$178K | ﹤0.01% | 3924 |
|
|
2016
Q1 | $1.25M | Sell |
88,980
-1,546
| -2% | -$21K | ﹤0.01% | 3740 |
|
|
2015
Q4 | $1.24M | Buy |
90,526
+61,301
| +210% | +$914K | ﹤0.01% | 3899 |
|
|
2015
Q3 | $388K | Sell |
29,225
-465
| -2% | -$5.85K | ﹤0.01% | 4752 |
|
|
2015
Q2 | $307K | Sell |
29,690
-7,315
| -20% | -$76.8K | ﹤0.01% | 5014 |
|
|
2015
Q1 | $382K | Buy |
37,005
+2,531
| +7% | +$28.6K | ﹤0.01% | 4821 |
|
|
2014
Q4 | $352K | Sell |
34,474
-9,803
| -22% | -$103K | ﹤0.01% | 4917 |
|
|
2014
Q3 | $421K | Sell |
44,277
-3,137
| -7% | -$29.4K | ﹤0.01% | 4682 |
|
|
2014
Q2 | $421K | Buy |
47,414
+28,579
| +152% | +$277K | ﹤0.01% | 4709 |
|
|
2014
Q1 | $200K | Sell |
18,835
-365
| -2% | -$3.38K | ﹤0.01% | 5125 |
|
|
2013
Q4 | $127K | Buy |
+19,200
| New | +$114K | ﹤0.01% | 5251 |
|
|
2013
Q3 | – | Sell |
-37,700
| Closed | -$156K | – | 5445 |
|
|
2013
Q2 | $156K | Buy |
+37,700
| New | +$170K | ﹤0.01% | 4951 |
|
Morgan Stanley's NCIT Position: Q3 2017 in Review
Morgan Stanley sold out of NCI, Inc. (NCIT) in Q3 2017, closing a stake of 54,729 shares — an estimated $1.15M sold.
Morgan Stanley first reported a position in NCIT in Q2 2013 and held it in 16 quarters. The position peaked at $1.25M in Q1 2016. 0 funds tracked by Wall St. Rank hold NCIT as of Q3 2017.
- Morgan Stanley reported no remaining NCI, Inc. position as of Q3 2017 after selling out during the quarter.
- Morgan Stanley sold 54,729 NCI, Inc. shares in Q3 2017, an estimated $1.15M.
- Morgan Stanley first reported a position in NCI, Inc. in Q2 2013 and held it in 16 quarters.
- Morgan Stanley's NCI, Inc. position peaked at $1.25M in Q1 2016.
- 0 funds tracked by Wall St. Rank held NCI, Inc. as of Q3 2017.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.